Article
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 May 2011
Warner Ellen, Hill Kimberley, Causer Petrina, Plewes Donald, Jong Roberta, Yaffe Martin, Foulkes William D, Ghadirian Parviz, Lynch Henry, Couch Fergus, Wong John, Wright Frances, Sun Ping, Narod Steven A
Abstract excerpt
PURPOSE: The sensitivity of magnetic resonance imaging (MRI) for breast cancer screening exceeds that of mammography. If MRI screening reduces mortality in women with a BRCA1 or BRCA2 mutation, it is expected that the incidence of advanced-stage breast cancers should be reduced in women undergoing MRI screening compared with those undergoing conventional screening. PATIENTS AND METHODS: We followed 1,275 women...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.